Learn More
Cayman Chemical SR 18292, 2095432-55-4, 10 mg

Supplier: Cayman Chemical 2208410
An inhibitor of PGC-1α, increases acetylation of PGC-1α; decreases mRNA expression of Pck1 and G6Pc in primary hepatocytes following glucagon stimulation; reduces fasting blood glucose and Pck1 expression in the liver in a dietary model of type II diabetes in mice at a dose of 45 mg/kg, i.p, for four days; enhances glucose tolerance and insulin sensitivity in two mouse models of obesity
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.